000 01559 a2200445 4500
005 20250515055903.0
264 0 _c20070724
008 200707s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2007.02.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLetavic, Michael A
245 0 0 _aNovel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cMay 2007
300 _a2566-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aDrug Design
650 0 4 _aHistamine
_xchemistry
650 0 4 _aHistamine Antagonists
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aModels, Chemical
650 0 4 _aMolecular Conformation
650 0 4 _aNaphthyridines
_xchemical synthesis
650 0 4 _aRats
650 0 4 _aReceptors, Histamine H3
_xchemistry
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xchemical synthesis
700 1 _aKeith, John M
700 1 _aLy, Kiev S
700 1 _aBarbier, Ann J
700 1 _aBoggs, Jamin D
700 1 _aWilson, Sandy J
700 1 _aLord, Brian
700 1 _aLovenberg, Timothy W
700 1 _aCarruthers, Nicholas I
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 17
_gno. 9
_gp. 2566-9
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2007.02.006
_zAvailable from publisher's website
999 _c16866442
_d16866442